BJL
LAB icon

Brighton Jones LLC’s Standard BioTools LAB Stock Holding History

Brighton Jones LLC’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.1K Buy
21,944
+10,465
+91% +$9.89K ﹤0.01% 1403
2026
Q1 		$10.6K Buy
+11,479
New +$13.9K ﹤0.01% 1195

Other funds holding LAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

Brighton Jones LLC's LAB Position: Q2 2026 in Review

Brighton Jones LLC increased its Standard BioTools (LAB) stake by 91% in Q2 2026, buying an estimated $9.89K and bringing the position to 21,944 shares worth $18.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1403.

Brighton Jones LLC first reported a position in LAB in Q1 2026 and has held it in 2 quarters since. 76 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Brighton Jones LLC held 21,944 shares of Standard BioTools worth $18.1K as of Q2 2026.
  • Brighton Jones LLC bought 10,465 Standard BioTools shares in Q2 2026, an estimated $9.89K.
  • Standard BioTools made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1403 holding.
  • Brighton Jones LLC first reported a position in Standard BioTools in Q1 2026 and has held it in 2 quarters since.
  • 76 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.